Lipoprotein Z, an abnormal LDL-like lipoprotein, independently predicts mortality in cirrhosis.
暂无分享,去创建一个
[1] M. Connelly,et al. Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein , 2022, Journal of clinical medicine.
[2] M. Connelly,et al. Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay , 2020, Journal of clinical medicine.
[3] L. Calabresi,et al. Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020. , 2020, Current opinion in lipidology.
[4] H. Scharnagl,et al. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. , 2020, Journal of hepatology.
[5] N. Mcintyre. Plasma lipids and lipoproteins in liver disease. , 1978, Gut.
[6] F. Purrello,et al. Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance , 2017, Digestive Diseases and Sciences.